Identification of an association between HLA class II alleles and low antibody levels after measles immunization

被引:92
作者
Poland, GA
Ovsyannikova, IG
Jacobson, RM
Vierkant, RA
Jacobsen, SJ
Pankratz, VS
Schaid, DJ
机构
[1] Mayo Clin & Mayo Fdn, Mayo Vaccine Res Grp, Dept Internal Med, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Dept Pediat & Adolescent Med, Rochester, MN 55905 USA
[3] Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Rochester, MN 55905 USA
关键词
measles; antibody response; HLA;
D O I
10.1016/S0264-410X(01)00346-2
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
This is the first large cohort study to report a genetic association between humoral antibody level after measles vaccine and the HLA class II genes. The WHO goal to eradicate measles world-wide magnifies the importance of data relating to the influence of immunogenetics on measles vaccine-induced antibody responses. We present here the analysis of 242 individuals who received one dose of measles-mumps-rubella-II (MMR-II) vaccine at the age of 15 months and were genotyped for HLA class II alleles. These subjects fit into one of three categories, 72 were classified as seronegative, 93 were seropositive and 77 were serohyperpositive. HLA-DRB1*03 (odds ratio (OR). 2.22) and HLA-DPA1*0201 (OR, 1.71) were significantly associated with measles vaccine seronegativity, while additional alleles provided suggestive evidence of association with seronegativity: DQA1*0201 DQB1*0201. and DQA1*0501. The alleles DRB1*03 and DQA1*0201 remained statistically significant after accounting for the effects of other alleles. These findings are crucial in designing both measles eradication by the use of vaccine, and future vaccines to be used in genetically heterozygous populations. (C) 2001 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:430 / 438
页数:9
相关论文
共 60 条
[1]   ROLE OF VIRUS-STRAIN IN CONVENTIONAL AND ENHANCED MEASLES PLAQUE NEUTRALIZATION TEST [J].
ALBRECHT, P ;
HERRMANN, K ;
BURNS, GR .
JOURNAL OF VIROLOGICAL METHODS, 1981, 3 (05) :251-260
[2]   HLA-DQB1 LOW-RESOLUTION TYPING BY PCR AMPLIFICATION WITH SEQUENCE-SPECIFIC PRIMERS (PCR-SSP) [J].
ALDENERCANNAVA, A ;
OLERUP, O .
EUROPEAN JOURNAL OF IMMUNOGENETICS, 1994, 21 (06) :447-455
[3]   HLA-DPA1 typing by PCR amplification with sequence-specific primers (PCR-SSP) and distribution of DPA1 alleles in Caucasian, African and Oriental populations [J].
AldenerCannava, A ;
Olerup, O .
TISSUE ANTIGENS, 1996, 48 (03) :153-160
[4]   GENETIC PREDICTION OF NONRESPONSE TO HEPATITIS-B VACCINE [J].
ALPER, CA ;
KRUSKALL, MS ;
MARCUSBAGLEY, D ;
CRAVEN, DE ;
KATZ, AJ ;
BRINK, SJ ;
DIENSTAG, JL ;
AWDEH, Z ;
YUNIS, EJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 321 (11) :708-712
[5]   Secondary failure rates of measles vaccines: A metaanalysis of published studies [J].
Anders, JF ;
Jacobson, RM ;
Poland, GA ;
Jacobsen, SJ ;
Wollan, PC .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 1996, 15 (01) :62-66
[6]   Peptide binding motifs and specificities for HLA-DQ molecules [J].
Baas, A ;
Gao, XJ ;
Chelvanayagam, G .
IMMUNOGENETICS, 1999, 50 (1-2) :8-15
[7]   A DNA-RFLP TYPING SYSTEM THAT POSITIVELY IDENTIFIES SEROLOGICALLY WELL-DEFINED AND ILL-DEFINED HLA-DR AND DQ ALLELES, INCLUDING DRW10 [J].
BIDWELL, JL ;
BIDWELL, EA ;
SAVAGE, DA ;
MIDDLETON, D ;
KLOUDA, PT ;
BRADLEY, BA .
TRANSPLANTATION, 1988, 45 (03) :640-646
[8]   ENZYME-LINKED IMMUNOSORBENT-ASSAY FOR DETECTION OF MEASLES ANTIBODY [J].
BOTELER, WL ;
LUIPERSBECK, PM ;
FUCCILLO, DA ;
OBEIRNE, AJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 1983, 17 (05) :814-818
[9]   ANTIBODY-RESPONSE FOLLOWING MEASLES-MUMPS-RUBELLA VACCINE UNDER CONDITIONS OF CUSTOMARY USE [J].
BRUNELL, PA ;
WEIGLE, K ;
MURPHY, MD ;
SHEHAB, Z ;
COBB, E .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1983, 250 (11) :1409-1412
[10]  
BRUNELL PA, 1990, MEASLES CONTROL 1990, P1